Skip to content
Screener

Alkermes ALKS EBITDA margin

EBITDA margin at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
30.7%+3.6pp
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
-10.9%-28.0pp
AbbVie logo
AbbVieABBV
37.3%
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
-23.5%-8.9pp
Indivior Pharmaceuticals, Inc. logo
Indivior Pharmaceuticals, Inc.INDV
26.5%+22.8pp
Harmony Biosciences Holdings, Inc. logo
Harmony Biosciences Holdings, Inc.HRMY
23.7%-5.7pp

Other financials

Income statement

See full
Revenue$496.0M+27.0%
Gross profit$397.9M+16.6%
Operating income$18.4M-80.3%
Net income$501.0K-99.4%
EPS (diluted)$0.00-100%

Balance sheet

See full
Cash & equivalents$511.5M-1.9%
Total debt$1.6B+2,064%
Total equity$1.8B+11.3%
Total assets$4.4B+95.0%

Cash flow

See full
Operating cash flow-$165.7M-268%
CapEx$8.1M-37.4%
Free cash flow-$169.8M-291%

Valuation

See full
Market cap$8.32B+89.9%
Enterprise value$9.38B+139%
P/E125.9×+113×
P/S+2.1×

Profitability

See full
Gross margin84.6%-0.6pp
Operating margin7%-17.8pp
Net margin4%-19.2pp
FCF margin14.2%-17.6pp

Returns & leverage

See full
Return on equity3.9%-20.1pp
Debt / equity0.9×+0.8×
Current ratio2.3×-0.9×

Where this comes from

Calculated from Alkermes’s reported figures.

Based on trailing twelve months.

The source filing: Alkermes’s 10-Q, filed July 28, 2026. Open the filing →

Filed
Jul 28, 2026, 9:22 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-319022

FAQ

What is Alkermes's EBITDA margin?
Alkermes (ALKS) reported EBITDA margin of 10.7% in Q2 2026.
How has Alkermes's EBITDA margin changed year-over-year?
Alkermes's EBITDA margin decreased by 60.0% year-over-year, from 26.8% to 10.7%.
What is the long-term trend for Alkermes's EBITDA margin?
Over 5 years (2020 to 2025), Alkermes's EBITDA margin has grown at a 45.3% compound annual growth rate (CAGR), from -2.9% to 19%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.

Ask your AI about Alkermes's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude